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A B S T R A C T
Amyotrophic lateral sclerosis (ALS) causes rapidly progressive paralysis and death within 5 years from diagnosis
due to degeneration of the motor circuits. However, a significant population of ALS patients also shows cognitive
impairments and progressive hippocampal pathology. Likewise, the mutant SOD1(G93A) mouse model of ALS
(mSOD1), in addition to loss of spinal motor neurons, displays altered spatial behavior and hippocampal ab-
normalities including loss of parvalbumin-positive interneurons (PVi) and enhanced long-term potentiation
(LTP). However, the cellular and molecular mechanisms underlying these morpho-functional features are not
well understood. Since removal of TrkB.T1, a receptor isoform of the brain-derived neurotrophic factor, can
partially rescue the phenotype of the mSOD1 mice, here we tested whether removal of TrkB.T1 can normalize
the number of PVi and the LTP in this model. Stereological analysis of hippocampal PVi in control, TrkB.T1−/−,
mSOD1, and mSOD1 mice deficient for TrkB.T1 (mSOD1/T1−/−) showed that deletion of TrkB.T1 restored the
number of PVi to physiological level in the mSOD1 hippocampus. The rescue of PVi neuron number is paralleled
by a normalization of high-frequency stimulation-induced LTP in the pre-symptomatic mSOD1/T1−/−mice. Our
experiments identified TrkB.T1 as a cellular player involved in the homeostasis of parvalbumin expressing in-
terneurons and, in the context of murine ALS, show that TrkB.T1 is involved in the mechanism underlying
structural and functional hippocampal degeneration. These findings have potential implications for hippocampal
degeneration and cognitive impairments reported in ALS patients at early stages of the disease.
1. Introduction
Amyotrophic lateral sclerosis (ALS) leads to paralysis and death. As
such, studies have been mainly focusing on circuits in the spinal cord
and motor cortex. While the central and peripheral motor circuits are
possibly at the epicenter of characteristic ALS symptoms, alterations of
circuits including those of the hippocampus - far away from sensory
inputs and motor outputs - are also present in ALS patients and in the
mutant SOD1(G93A) mouse (mSOD1) model of ALS (Abdulla et al.,
2014; Phukan et al., 2007; Quarta et al., 2015; Takeda et al., 2009).
These changes may account for the cognitive deficits observed in about
half of the ALS patients (Abrahams et al., 2005; Lillo and Hodges, 2010;
Ringholz et al., 2005).
A pivotal component of hippocampal circuits is represented by in-
hibitory GABAergic, fast-spiking parvalbumin-positive interneurons
(PVi; (Bartos et al., 2002; Baude et al., 2006; Kawaguchi et al., 1987).
Hippocampal PVi comprise a subset of axo-axonic, basket, and bis-
tratified cells. Functionally, these cells grant synchronized oscillatory
inputs to pyramidal neurons (Klausberger, 2005). At the behavioral
level, hippocampal PVi are relevant for hippocampus-dependent per-
formance, including spatial learning and memory (Murray et al., 2011).
Recently, we have reported a reduction in this population of PVi in
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pre-symptomatic mSOD1 mice concurrently with increased anxiety-like
behavior and impaired spatial navigation behavior (Quarta et al.,
2015). However, the cellular and molecular reasons underlying these
latter pathological features are not well understood.
The development and function of selected neural cells, including
GABAergic interneurons, is under tight control by brain derived neu-
rotrophic factor (BDNF), and its cognate receptor tropomyosin receptor
kinase B (TrkB; Angelov and Angelova, 2017; Barde et al., 1982; Klein
et al., 1989; Waterhouse et al., 2012; Zheng et al., 2011). Alternative
splicing generates a catalytic form of TrkB (full length TrkB, TrkB.FL)
and truncated isoforms lacking the intracellular kinase domain
(TrkB.T1, TrkB.T2, and TrkB.T-Shc; Klein et al., 1990; Wong and
Garner, 2012).
TrkB·FL signaling induces, via the PI3K/AKT, RAS/MAPK, PLC/PKC,
AMPK/ACC and JAK/STAT pathways, proliferation, survival, and dif-
ferentiation effects and contributes to the synaptic plasticity main-
tenance (Huang and Reichardt, 2003). TrkB.T1 (T1) is the predominant
TrkB isoform in the mature brain (Dorsey et al., 2006) and has a more
elusive and less studied signaling (Fenner, 2012; Ferrer et al., 1999;
Fryer et al., 1996; Silhol et al., 2005). A canonical function of T1 is to
act as the dominant-negative receptor to inhibit TrkB·FL signaling to
decrease the pro-survival BDNF effects on neuronal survival, differ-
entiation, and plasticity (Fig. 1). However, cells from both CNS (Rose
et al., 2003) and peripheral organs such as the heart respond directly to
BDNF through TrkB.T1 with release of calcium from internal stores
(Fulgenzi et al., 2015). Furthermore, deletion of the T1 isoform induces
alterations in the CNS (Carim-Todd et al., 2009), skeletal (Dorsey et al.,
2012) and cardiac muscle (Fulgenzi et al., 2015).
It is currently not known whether endogenous T1 is involved in the
maintenance of the hippocampal PVi. In the present study we first in-
vestigated this aspect, by performing a stereological quantification of
the hippocampal PVi population in TrkB.T1 knockout mice.
Alterations in BDNF/TrkB signaling have been associated with
neurological disorders, including ALS. Hence, the study of the organi-
zation and targeting BDNF/TrkB signaling holds great promise to treat
neurodegenerative conditions (Angelov and Angelova, 2017; Angelova
and Angelov, 2017; Angelova et al., 2013; Geral et al., 2013; Guerzoni
et al., 2017). However, in ALS exogenous BDNF delivery does not
protect against neurodegeneration and, surprisingly, endogenous BDNF
expression is increased in this clinical population, while phosphoryla-
tion levels of TrkB are reduced (Kust et al., 2002; Mutoh et al., 2000).
In the mSOD1 mouse model of ALS, T1 limits the pro-survival effects
of BDNF on motoneurons (Yanpallewar et al., 2012a). From this ob-
servation, we therefore theorized that the dominant negative receptor
T1, by negatively regulating the BDNF/TrkB pro-survival signaling,
could be involved in the loss of hippocampal PVi observed in the
mSOD1 model. To test this hypothesis, we evaluate the impact of T1
deletion on the PVi population in mSOD1 mice.
BDNF-TrkB signaling and PVi are implicated in the regulation of
long-term potentiation (LTP), a cellular model of learning (Kumar,
2011; Leal et al., 2015; Levine et al., 1995), which was shown to be
abnormally increased in the mSOD1 mouse (Spalloni et al., 2006). In an
attempt to determine the relevance of T1 in these measures of synaptic
strength, we performed experiments to evaluate the impact of T1 de-
letion on LTP in mSOD1 mice.
2. Materials and methods
SOD1(G93A) mice [B6SJL-TGN(SOD1-G93A)1GUR/J; 002726]
were acquired from The Jackson Laboratory (Bar Harbor, ME) and
crossed to T1 knockout mice backcrossed on C57/B16J background for
at least 10 generations (Yanpallewar et al., 2012a). Experimental
groups were mSOD1, wild-type littermates (wt), T1 knockout (T1−/−)
and mSOD1/T1−/− mice. All mice were 8 weeks old.
Animals were kept under controlled environmental parameters and
veterinarian assistance. All animals were infection-free, were kept
under constant light/dark (12/12 h) cycle and fed a diet of rodent chow
and water ad libitum. Care was taken to avoid animal stress and dis-
comfort during handling and surgery. All experiments were conducted
with the experimenter blind to the genotype of the animals. Protocols
followed the National Institutes of Health Guidelines for animal care
and use of laboratory animals, and were approved by the NCI-Frederick
ACUC committee.
2.1. Immunohistochemistry
The immunohistochemical procedure for the visualization of PVi
has been previously described (Quarta et al., 2015). Briefly, animals
were deeply anesthetized (Avertin 250mg/kg i.p.) and perfused trans-
cardially with PBS, followed by 4% paraformaldehyde in 0.1 M PBS,
pH 7.4. Brains were dissected out, soaked overnight in 30% buffered
sucrose at 4 °C, and cut on a cryostat microtome into 40 μm thick cor-
onal sections. The dorsal hippocampus was investigated between
−1.46/−1.58mm and− 2.70/−2.80mm from bregma (anterior and
posterior limit, respectively; (Paxinos and Franklin, 2013). Every fifth
section containing the hippocampus was collected for the im-
munohistochemical study of PVi. Some sections were collected sepa-
rately for thionin staining in order to determine hippocampal cy-
toarchitecture (0.25% thionin solution; (Armed Forces Institute of
Pathology (U.S.) and Luna, 1968). Sections processed for PV im-
munohistochemistry were incubated in 3% normal goat serum for 1 h
and then in monoclonal mouse anti-PV antibodies (Sigma-Aldrich,
mouse monoclonal, PARV-19, #P3088, RRID:AB_477329, 1:10000), in
PBS/0.3% Triton X-100/3% normal goat serum, for 36 h at 4 °C. All
sections were then incubated in goat anti-mouse biotinylated secondary
antibodies (Sigma-Aldrich Co., Cat# B7264, RRID:AB_258607, dilution
1:200) in PBS/0.3% Triton X-100 for 1 h, followed by the avidin–biotin
procedure (Pierce, Rockford, IL, USA), and reacted with 3,3′-diamino-
benzidine dihydrochloride (Sigma-Aldrich). Sections were then
mounted on gelatin-coated slides, dehydrated, and coverslipped (Eu-
kitt, Kindler, Germany).
Digital images were acquired with CCD video camera module (20×
HI PLAN Leica objective). The entire coronal section of dorsal hippo-
campus was reconstructed by joining the acquired images and then
analyzed with the public domain ImageJ program (Schneider et al.,
2012). All cell profiles were counted for each acquired hippocampal
section. As in our previous investigations (Del Tongo et al., 2009;
Quarta et al., 2015) estimates were performed on the hippocampus of
both hemispheres and are reported here as PVi per hippocampus.
Quantitative evaluations were performed by using the optical dissector
method on counts of cell profiles (Schmitz and Hof, 2005; Sterio, 1984).
Image reconstructions were printed out and we analyzed, at the mi-
croscope stage under high magnification (40× HI PLAN Leica objec-
tive), the same sections with the focus on the upper surface (i.e., the
look-up section). The somatic profiles in the focus, through the ob-
servation of the look-up section, were marked on the printouts,
counted, and subtracted from the total cell counts of the image re-
constructions (Jinno and Kosaka, 2002, 2009) to obtain the value N,
which expresses the estimated number of PVi per section.
The number of PVi counted per dorsal hippocampus was calculated
as follows:
= + +…+ ×Cc (Ns1 Ns2 Nsn) 5
where s represents the single section and n is the last section counted
(typically, 6 sections were counted per animal).
2.2. Electrophysiology
Electrical stimulation of Schaffer collaterals generates excitatory
postsynaptic potentials (EPSP) in the postsynaptic CA1 neuron. Brief,
high-frequency trains of stimuli (HFS) to the Schaffer collaterals cause
LTP, which is quantified as the normalized field EPSP (fEPSP) response
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at 55–60min after tetanus stimulation (Bliss and Lømo, 1973; Lomo,
1966).
Mice were placed under deep anaesthesia (Avertin, 250mg/kg i.p.)
and transcardially perfused with 25–30ml of room temperature car-
bogenated N-methyl-D-glucamine artificial cerebrospinal fluid (NDMG-
ACSF composition in mM: N-methyl-D-glucamine 93, HCl 93, KCl 2.5,
NaH2PO4 1.2, NaHCO3 30, HEPES 20, Sodium ascorbate 5, Thiourea 2,
Sodium pyruvate 3, Glucose 25, MgSO4 10, CaCl2 0.5, N-acetyl-L-
Cysteine 12, pH 7.4, 300–310mOsm), which has been shown to facil-
itate the preservation of the GABAergic interneurons activity, including
that of PVi (Pan et al., 2015; Ting et al., 2014). Brains were gently
extracted from the skull within 1min, sectioned at 300 μm with a vi-
broslicer (Leica) incubated for further 10min in the same NMDG-ACSF
at 37 °C and then transferred in the holding solution (Composition in
mM: NaCl 92, KCl 2.5, NaH2PO4 1.2, NaHCO3 30, Hepes 20, Glucose
25, Sodium ascorbate 5, Thiourea 2, Sodium pyruvate 3, MgSO4 2,
CaCl2 2, N-acetyl-L-Cysteine 12, pH 7.4, 300–310mOsm) until used for
recording. Samples (wt, n=9 slices; mSOD1, n=8 slices; mSOD1/
T1−/−, n= 8 slices) were used within 10 h after sectioning. Slices were
perfused with ACSF (Composition in mM: NaCl 124, KCl 2.5, NaH2PO4
1.2, NaHCO3 24, Hepes 5, Glucose 12.5, MgSO4 2, CaCl2 2, pH 7.4,
300–310mOsm) at 28 °C at the rate of 2ml/min. No other drugs were
used during the recording. For the recordings, two Teflon-coated con-
centric platinum–iridium electrodes were placed in the stratum ra-
diatum in the CA1 subfield of the dorsal hippocampus, 300–400 μm
apart. Borosilicate glass recording electrodes were pulled (Sutter
Fig. 1. Molecular structure of TrkB isoforms and morphofunctional components investigated in the present work.
A. Schematic representation of the molecular structure of TrkB isoforms in the lipid membrane (full length= FL, truncated isoform T1). Extracellularly, the TrkB
receptors are formed by a combination of Cysteine Rich Repeats, Leucine Rich Repeats and Immunoglobulin domains that is identical across isoforms. Intracellularly,
the tyrosine kinase domain (TKD) is unique to the FL isoform. In the presence of brain-derived neurotrophic factor (BDNF), TrkB·FL homodimerization leads to
receptor autophosphorylation at the TKD and downstream signaling (e.g., via the phosphorylation of PLC, PI3K, MAPK) to induce cell proliferation, survival/death,
differentiation as well as plasticity. The TrkB.T1 isoform contains a short intracellular domain and lacks the TKD. In the presence of BDNF, T1 forms a heterotimer
with FL, to exert its dominant negative inhibition (interrupted line in the figure) of FL-mediated signaling. In astrocytes, T1 is the only expressed isoform, where it
controls the sequestration of BDNF. Note that while FL and T1 are the main isoforms, other isoforms exist, i.e., T2 e SHC (not shown).?= unknown intracellular
signaling.
B, C, D. Morphofunctional components investigated in the present study: we focus our neuroanatomical analysis on a subpopulation of hippocampal inhibitory
neurons that express parvalbumin (PV), the PV+ interneurons (PVi). B. Schematics of the charts PVi; our structural approach on PVi is complemented with
electrophysiological investigation (C, D) aimed at comparing synaptic plasticity at the Schaffer's collateral, via classic LTP experiments.
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Instruments P90), ACSF filled to get 4–7MΩ resistance, and placed in
the apical dendritic region of CA1 pyramidal neurons evenly spaced
with respect to the stimulating electrode. Field potentials were obtained
by alternate stimulation of the two electrodes by activation of the
Schaffer collaterals. One of the electrodes was used as a control elec-
trode, whereas the other was used to deliver the conditioning protocol.
Stimulation intensity for the two channels was set so that the response
was 50% of the maximal response. Input/Output analysis was per-
formed at the begin of each recording for all slices. Stimulus intensity
was increased in discrete step from 0 until maximal response was
achieved. 10 fEPSP were recorded and averaged for each level. Fiber
Volley amplitude was measured with respect to baseline level (i.e.
average of the signal on the 15ms preceding the stimulus) and plotted
against the initial fEPSP slope.
Baseline recording was obtained by stimulating the slice every 20 s
for at least 45min. Once the baseline was stabilized to obtain LTP, two
100 Hz trains (lasting 1 s each) every 20 s were delivered to the sti-
mulating electrode. Baseline recording was then resumed and followed
for 1 h. Field potential was recorded (Multiclamp 700b; Axon
Instruments), digitized (10 kHz Digidata 1324), low-pass filtered
(3 kHz, eight-pole Bessel), and stored (Clampex 9.2; Axon Instruments).
Signals were analyzed off line (Clampfit 9.2; Axon Instruments), and the
size of the fEPSP was evaluated by measuring the initial slope of the
signal expressed as percentage of the variation from the baseline value
(average of 5min before the conditioning protocol; Carim-Todd et al.,
2009; Yanpallewar et al., 2012b). Slices that showed>5% difference
from baseline to the end of recording measured at the control electrode
where discarded. Paired Pulse was obtained for delays of 20ms (with
20ms increment every 20 s up to 400ms) using the control stimulating
electrode and calculating the ratio of the rising slope (10% to 60%) of
the first to the second fEPSP.
2.3. Statistical analysis
Immunohistochemical data are shown per group as mean ±
standard deviation. Data of wt, mSOD1, T1−/− and mSOD1/T1−/−
mice are compared with one-way or two-way ANOVA, and Bonferroni's
post hoc test. Electrophysiological results are presented as percentage of
the baseline slope of fEPSP ± standard error of the mean and followed
by ANOVA and Bonferroni's post hoc test, when necessary.
3. Results
3.1. Hippocampal parvalbumin-positive interneurons
Neurons across genotypes displayed gross morphological similarity
and comparable spatial distribution. Most of the PVi were present in the
stratum pyramidale of CA1, CA2, and CA3, and in the granular layer
and hilus of DG (Fig. 2A–D). The majority of PVi were small- to
medium-sized fusiform cells, and triangular neurons (Fig. 2, insets
A1–D2).
We have previously reported that the mSOD1 mouse displays a re-
duced number of PVi in the hippocampus already at a pre-symptomatic
phase (Quarta et al., 2015). To assess whether T1 is involved in the
maintenance of hippocampal PVi population we performed unbiased
stereological estimations of these neurons, separately for the four
genotypes. The analysis revealed quantitative differences in the hip-
pocampal PVi populations among the different genotypes (two-way
ANOVA, genotype effect: F(3,167) = 50.85, p < 0.01).
When analyzed separately for the four hippocampal subfields, post-
hoc tests showed that these findings arise from subfield-specific dif-
ferences among genotypes. The number of PVi in DG and CA2 was
comparable among the experimental groups, albeit trend towards nu-
merical increase (for T1) and decrease (for mSOD1) compared to wt
were observed. In particular, the estimations of PVi in the DG were
106.33 ± 26.54 in wt, 75.36 ± 19.94 in mSOD1, 130.39 ± 30.96 in
T1−/−, and 106.25 ± 17.27 in mSOD1/T1−/− mice (Fig. 3 DG).
Analogous results were obtained for the PVi populations in CA2 (wt:
95.28 ± 14.49, mSOD1: 61.11 ± 11.37; T1−/−: 97.82 ± 9.47,
mSOD1/T1−/−: 87.29 ± 19.08; Fig. 3 CA2).
In line with our previous study (Quarta et al., 2015), the PVi po-
pulation was found reduced in mSOD1 mice compared to wt animals,
for both CA1 (wt: 422.56 ± 70.63, mSOD1: 323.12 ± 55.57,
p < 0.001; Fig. 3 CA1), and CA3 (wt: 433.86 ± 118.50, mSOD1:
279.20 ± 42.95, p < 0.001; Fig. 3 CA3). The estimate of hippocampal
PVi in mice deficient for this receptor isoform indicated that the PVi
population in CA1 did not differ between T1 deficient mice and control
animals (wt: 422.56 ± 70.63, T1−/−: 451.45 ± 72.76; Fig. 3 CA1).
At variance with results obtained in CA1, the deletion of this receptor
led to an increase in the number of PVi that was observed only in CA3
(wt: 433.86 ± 118.50, T1−/−: 565.98 ± 22.27, p < 0.001; Fig. 3
CA3). To our knowledge, these data provide the first evidence for a role
of T1 in the maintenance of hippocampal interneurons.
To assess whether T1 is involved in the loss of hippocampal PVi
occurring in mSOD1 mice, we next compared the stereological esti-
mates of these interneurons in mSOD1/T1−/− mice with the quantifi-
cations of PVi number obtained from wt and mSOD1 mice. The number
of PVi in mSOD1/T1−/− was comparable to that of wt mice in CA1 (wt:
422.56 ± 70.63, mSOD1/T1−/−: 395.83 ± 44.66; Fig. 3 CA1), which
is indicative for a complete rescue of PVi in this subfield. In the CA3
there was a significant increase in the population of PVi in mSOD1/
T1−/− mice compared to mSOD1 animals (mSOD1: 279.20 ± 42.95,
mSOD1/T1−/−: 344.79 ± 27.13; p < 0.001). However, this numer-
ical increase did not fully compensate the PVi loss, as the population of
these interneurons was lower in mSOD1/T1−/− mice compared to wt
animals (wt: 433.86 ± 118.50, mSOD1/T1−/−: 344.79 ± 27.13;
p < 0.001; Fig. 3 CA3). Together, these findings indicate that T1 takes
part in the loss of hippocampal PVi occurring in pre-symptomatic
mSOD1 mice.
3.2. Synaptic plasticity
To investigate whether the rescue of PVi observed in mSOD1 mice
knocked-out for T1 also affect the efficiency of synaptic communica-
tion, we assessed LTP at the Schaffer collaterals in mice of the three
genotypes (wt, mSOD1, and mSOD1/T1−/−, Fig. 3). In the past, we
reported the recordings for T1−/− mice, showing that endogenous
expression of this receptor is not necessary for LTP elicited by HFS
(Carim-Todd et al., 2009).
Acute hippocampal slices from wt, mSOD1, and mSOD1/T1−/−
animals were stimulated in CA3 and recordings of fEPSP were obtained
in CA1 (Fig. 4A–C).
No differences between genotypes were observed in terms of basal
synaptic communication, as assessed by the input–output curves from
the CA3–CA1 subfields (Supplementary Fig. 1, A). Moreover, in the
context of the mSOD1 mouse, we found that TrkB.T1 does not modulate
paired pulse facilitation (Supplementary Fig. 1, B–C).
We compared LTP in CA1 of the dorsal hippocampus 50min post-
HFS (Fig. 4 A-D). At this time point, we observed differences between
genotypes (one-way ANOVA; wt: 15.73 ± 2.5; mSOD1: 34.5 ± 6.47;
mSOD1/T1−/−: 19.63 ± 1.12, genotype effect: F(2,24) = 6.26,
p < 0.01). The values for mSOD1 mice were higher compared to wt
mice (pairwise comparison: p < 0.01).
A significant difference was observed when comparing mSOD1 with
mSOD1/T1−/− (pairwise comparison: p=0.0336). Importantly, the
values of mSOD1/T1−/− and wt mice were similar, indicating that the
LTP levels were normalized in mSOD1 deficient for T1.
4. Discussion
We reported here experiments carried out to assess the influence of
the BDNF receptor TrkB.T1 on hippocampal physiopathology in murine
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ALS. We found that this receptor i) takes part in the maintenance of the
PVi population in specific hippocampal subfields and ii) is involved in
two morpho-functional features of the hippocampal phenotype ob-
served in the mSOD1 mouse, i.e., the loss of PVi and the increased LTP.
While the spinal pathology has been well characterized in ALS, only
in recent years the potential contribution of cortical pathology has
begun to be investigated. Currently, there is increasing interest in
identifying cortical components that may regulate motor neuron sur-
vival and function, and recent reports have uncovered an interneuron
pathology in motor cortex as well as non-cortical regions in ALS (Clark
et al., 2017; Minciacchi et al., 2009).
4.1. TrkB.T1 influence on PVi maintenance and rescue of PVi loss by
TrkB.T1 deletion in the mSOD1 mouse
Our results unveil for the first time that the PVi population in the
hippocampus is increased in mice lacking this receptor isoform. Results
indicate that the numerical increase of PVi is significant for CA3. This
finding may be suggestive for a subfield specific action of T1; however,
considering that CA3 is the largest subfield in the hippocampus, it re-
mains possible that the differences observed in this subfield may more
easily reach statistical significance compared to CA1, CA2, and DG,
where we nonetheless observed a trend towards increase of PVi
number. While it remains to be determined if T1 exert a subfield spe-
cific influence or a generalized action on these neurons, our results
strongly point to this receptor as an important intracellular player in-
volved in PVi maintenance, which could in turn influence hippocampal
information processing.
Abnormal T1 levels have been documented in other neurodegen-
erative disorders, such as Alzheimer's disease (Ferrer et al., 1999; Silhol
et al., 2005) and Down syndrome, a disorder also associated with
cognitive deficits (Dorsey et al., 2002; Hernandez and Fisher, 1996).
The accelerated death of hippocampal neurons in a mouse model for
Down syndrome, is not rescued by exogenous BDNF delivery (Dorsey
et al., 2002) but instead by restoring the physiological levels of T1
(Dorsey et al., 2006). It is currently unknown if the expression levels of
Fig. 2. The topographic distribution and gross morphology of hippocampal PVi in wt and mSOD1 mice are not influenced by TrkB.T1.
Histological sections of the hippocampus illustrate the topology of PVi (20×) for representative wt (A), mSOD1 (B), T1−/− (C), mSOD1/T1−/− mice (D).
Distribution of PVi in the different subfield is preserved across genotypes. Two insets, one for CA1 and one for CA3 (40×), display morphological features of PVi for
wt (A1–A2), mSOD1 (B1–B2), T1−/− (C1–C2), mSOD1/T1−/− mice (D1–D2). Note how the neuronal morphology (insets) appears comparable among genotypes. In
the CA1–3 subfields, PVi are mostly distributed in the stratum pyramidale, while in the DG they are found mainly in the granular layer. Both scale bars: 100 μm (large
scale for insets).
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T1 are increased in the hippocampus or region-specific PVi selectively
overexpress TrkB.T1 in mSOD1 mouse model of ALS. It should be noted
that expression of T1, indeed, has been reported in PVi in the brain
(Bracken and Turrigiano, 2009; Ohira and Hayashi, 2009). Regardless,
the current findings point to a significant contribution of T1 to the
hippocampal PVi neurodegeneration occurring in the mSOD1 mouse.
Previously, we also reported that T1 participates in the early loss of α-
motorneurons in this ALS model (Yanpallewar et al., 2012a). Here, we
provide evidence indicating that other types of neurons, in another CNS
region, i.e. PVi in the hippocampus, are also susceptible to the reg-
ulation by T1 in mSOD1 mice. We speculate that this receptor could be
an active cellular player mediating the effect of the mutant protein or it
blunts the trophic effects of the TrkB·FL in the PVi. In the light of
present results, it is possible that, in ALS, antagonizing T1 action could
result in reduced hippocampal interneuron degeneration.
4.2. Autocrine and/or paracrine influence of TrkB.T1 on PVI in mSOD1
mice
The genetic deletion of T1 likely bears at least two neural outcomes
that affect intracellular signaling and possibly mediate the effects
observed herein: from one side, the loss of dominant-negative inhibition
in neurons, on the other side the lack of TrkB.T1-induced signaling in
astrocytes.
While the co-localization of T1 and PVi has been reported in the
visual cortex (Bracken and Turrigiano, 2009; Ohira and Hayashi, 2009),
it is unknown if the same expression pattern is present in the hippo-
campus. If expressed in PVi, T1 could limit pro-survival effects of BDNF
signaling. Interestingly, deletion of TrkB results in PVi loss (Zheng
et al., 2011), supporting the hypothesis that PVi are dependent on TrkB
signaling. Pyramidal neurons, known to express T1, were shown to be
sensitive to T1 manipulation (Michaelsen et al., 2010) and could in-
fluence the homeostasis of PVi.
Additionally or alternatively, T1 could indirectly influence hippo-
campal PVi via astrocytes; T1 is the only TrkB isoform expressed in
these glia cells, where it regulates calcium signaling (Matyas et al.,
2017; Rose et al., 2003). In the future it will be important to address
whether astrocytes, through BDNF-T1 mediated calcium signaling,
regulate the GABAergic neurons survival and function and if T1 dele-
tion has any relevance on the astrogliosis known to occur in the mSOD1
mouse.
GABAergic synaptic efficacy can be regulated by removal of GABA
Fig. 3. TrkB.T1 shrinks the population of hippocampal PVi in wt and in mSOD1 mice.
Stereological estimations of hippocampal PVi populations are shown, for each subfield, in graphs for wt (n=6), mSOD1(n=5), T1−/− (n= 6), mSOD1/T1−/−
(n=6) mice. For each graph, the ordinate indicates the PVi number. The number of PVi is comparable among groups in DG and CA2. T1 deletion results in an
increase of PVi number in CA3. In mSOD1 mice both the PVi populations of CA1 and CA3 are found to be reduced compared to wt animals. Knocking out T1 in
mSOD1 mice completely restores PVi population in CA1; in CA3, PVi number increases with respect to mSOD1 mice, albeit below the level of controls. Asterisks
denote statistical significant differences (*= p < 0.05; ***= p < 0.01).
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and this effect is enhanced in astrocytes upon BDNF stimulation (Vaz
et al., 2011). Furthermore, astrocytes modulate inhibitory synapse
formation via distinct presynaptic and postsynaptic mechanisms in-
volving BDNF (Elmariah et al., 2005). It is therefore conceivable that
astrocytic BDNF-T1 signaling could affect the homeostasis of hippo-
campal GABAergic neurons and the excitatory neurotransmission
(Boddum et al., 2016; Losi et al., 2014).
While the cellular mechanisms mediating the results presented
herein remain to be discovered, our work encourage future enquiries,
including conditional knock-out of T1 in PVi, in other neuron types, or
in astrocytes, to determine the cell type-specific roles of T1 on inter-
neuron and LTP homeostasis.
4.3. A link between PVi, BDNF signaling and LTP in SOD1 mutant mice?
Our results extend the knowledge on electrophysiological abnorm-
alities in the hippocampus of the mSOD1 mouse (Spalloni et al., 2006),
indicating that LTP enhancement occurs in an early pre-symptomatic
phase. As blocking GABA-mediated transmission facilitates LTP induc-
tion at excitatory synapses (Meredith et al., 2003; Wigström and
Gustafsson, 1983), we suspect that a decrease in the PVi population
may lead to a reduced inhibitory input, which would at least partially
account for the increased LTP observed in the mSOD1 mouse.
Accordingly, LTP increases have also been reported in concomitance
with decreases of hippocampal PVi number in other neurodegenerative
conditions (Auffret et al., 2010; Levenga et al., 2013; McEachern and
Shaw, 1999; Nisticò et al., 2013). If an inverse relation links the GA-
BAergic PVi population and LTP, hyperexcitability induced by PVi loss
should facilitate LTP, as it is indeed the case (Casasola et al., 2004).
Consistently, in ALS patients, cortical hyperexcitability appears to be
closely related to the altered interplay between excitatory cortico-mo-
toneurons and inhibitory interneurons (Bae et al., 2013). Our results in
the mSOD1 model extend this notion to hippocampal circuits and en-
courage future enquiry in ALS patients. Since it has been reported that
increased hippocampal activation is a dysfunctional condition and that
targeting excess hippocampal activity has therapeutic potential (Bakker
et al., 2012), counterbalancing for the hippocampal hyperactivity may
be beneficial for the cognitive profile of ALS patients.
Previous report indicate that BDNF enhances synaptic transmission
in hippocampal neurons via postsynaptic TrkB receptors (Levine et al.,
1995). The post-synaptic argument would fit well with our results in-
dicating a complete rescue of PVi in CA1 of mSOD1 mice deficient for
T1. However, since the PVi population is partially restored in CA3, we
cannot rule out that presynaptic neurotransmitter release could also be
altered by an increase in the number of PVi neurons leading to en-
hanced GABA transmission. PVi-specific genetic deletion of TrkB cause
Fig. 4. TrkB.T1 enhances LTP in presymptomatic mSOD1 mice.
Representative fEPSP recordings from wt (A), mSOD (B) and mSOD1/T1−/− (C) animals. For each case, the traces are obtained before (gray) and 50min (green) after
the high-frequency stimulation (HFS) conditioning protocol (2 times at 100ms, 100 Hz trains). The mSOD1 mice (n=8 slices) exhibit enhanced levels - with respect
to wt mice (n=9 slices) - of long-term potentiation (LTP) 50min following HFS; at the same time point, mSOD1/T1−/− mice (n=8 slices) display levels of LTP
resembling those of wt mice (D). Following HFS, the potentiation of fEPSP is higher in mSOD1 mice compared to wt mice; the post-HFS fEPSP is comparable between
wt mice and mSOD1/T1−/− mice (E). Asterisks denote statistical significant differences (*= p < 0.05). (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
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a 20% loss of these neurons and alters hippocampal gamma (30 to
90 Hz range) oscillations (Buzsáki and Wang, 2012; Zheng et al., 2011),
advocating for a pivotal role of TrkB in PVi survival and function and -
more specifically - in network communication. Changes in hippocampal
oscillations has been associated to changes of LTP (Bikbaev, 2007;
Kalweit et al., 2017).
LTP is normally related with animal learning. Therefore, the in-
creased LTP level observed in the pre-symptomatic mSOD1 mouse ap-
parently stride with the abnormal spatial behavior observed in our
previous work (Quarta et al., 2015). Intriguingly, increased LTP has
also been associated with impaired learning (Migaud et al., 1998) and it
has been suggested that saturation of LTP may reduce information-
storage capacity, consistent with theories proposing that plasticity may
be detrimental to network efficiency (Cohen et al., 2015, 2017; Roth-
Alpermann et al., 2006; Woollett and Maguire, 2009).
In the context of the mSOD1 mouse, our results suggest that T1
deletion act as “LTP-desaturation” strategy since T1 does not alter LTP
in physiological conditions (Carim-Todd et al., 2009). It is important to
underline that the implications of our electrophysiological findings
must be contextualized to the HFS protocol employed. For example,
theta-burst stimulation (TBS) elicits LTP via intracellular pathways that
are partially different from those involved in HFS (Zhu et al., 2015). As
such, the relative influence of T1 for induction and maintenance of LTP
could vary depending on to the stimulation paradigm. In the future
investigations, testing other LTP-inducing paradigms such as those
based on BDNF might unravel novel roles for T1 in synaptic function.
Future studies will determine whether T1 modulates the perfor-
mance in spatial navigation tasks. T1 has been shown to regulate an-
xiety-like behavior (Carim-Todd et al., 2009) and sleep (Watson et al.,
2015). Given the robust interplay between spatial navigation and sleep
(Guan et al., 2004; Nguyen et al., 2013; Ravassard et al., 2016), and
between anxiety and spatial navigation (Hund and Minarik, 2006), at
least subtle aspects of this latter behavior may be affected in the T1−/−
mouse, especially during adulthood, when T1 becomes the predominant
TrkB isoform (Fenner, 2012; Silhol et al., 2005). Considering that ma-
nipulating the expression of T1 or TrkB·FL alters the spatial behavior
impairments in a mouse model of Alzheimer's disease (Kemppainen
et al., 2012), an important question that remains open is whether T1
deletion may be a viable strategy to rescue, at least in part the cognitive
abnormalities of the mSOD1 mouse.
In conclusion, this study provides the first evidence for a role of T1
in the survival of hippocampal PVi, and suggest that antagonizing the
activity of this receptor may help attenuating hippocampal GABAergic
dysfunctions and normalize the synaptic plasticity in mSOD1 mouse.
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